Stockreport

Unicycive Therapeutics Announces Full Year 2024 Financial Results and Provides Business Update

Unicycive Therapeutics, Inc.  (UNCY) 
PDF       - Oxylanthanum carbonate (OLC) New Drug Application for hyperphosphatemia in chronic kidney disease patients on dialysis under review by the FDA with a PDUFA targe [Read more]